22 min listen
Thyroid Cancer with Dr Lori Wirth
Thyroid Cancer with Dr Lori Wirth
ratings:
Length:
51 minutes
Released:
Aug 19, 2021
Format:
Podcast episode
Description
Dr Lori Wirth from the Massachusetts General Hospital in Boston discusses the latest clinical data and ongoing investigations on targeted therapeutic approaches for the management of RET-altered and NTRK fusion-positive thyroid cancers.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayThyroid21/Issue1).
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayThyroid21/Issue1).
Released:
Aug 19, 2021
Format:
Podcast episode
Titles in the series (100)
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle: Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations. by Oncology Today with Dr Neil Love